SEVEN AND EIGHT BIOPHARMACEUTICALS
Seven and Eight Biopharmaceuticals is a biopharmaceutical company that develops proprietary novel immuno-oncology therapies.
SEVEN AND EIGHT BIOPHARMACEUTICALS
Industry:
Biopharma Biotechnology Clinical Trials Therapeutics
Founded:
2012-01-01
Address:
Edison, New Jersey, United States
Country:
United States
Website Url:
http://www.7and8biopharma.com
Total Employee:
1+
Status:
Active
Contact:
+1 (848) 300-0086
Email Addresses:
[email protected]
Current Employees Featured
Founder
Official Site Inspections
http://www.7and8biopharma.com Semrush global rank: 4.44 M Semrush visits lastest month: 2.49 K
- Host name: 211.7.230.35.bc.googleusercontent.com
- IP address: 35.230.7.211
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Seven and Eight Biopharmaceuticals"
Seven and Eight Biopharmaceuticals - Crunchbase
Organization. Seven and Eight Biopharmaceuticals . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number +1 (848) 300-0086; …See details»
Seven and Eight Biopharmaceuticals Inc. - SignalHire
Organization Website: 7and8biopharma.com : Phone Number: 1-848-300-0086: Seven and Eight Biop... industries Pharma: Headquarters Location: 343 Thornall Street, Edison, NJ, 08837 US …See details»
Seven and Eight Biopharmaceuticals Inc. | LinkedIn
Redefining Cancer Research & Treatment Seven and Eight Biopharmaceuticals Inc. is an experienced biopharmaceutical company committed to discovering and developing new and …See details»
Eight Biopharmaceuticals Company Profile | Management and
Eight Biopharmaceuticals Profile and History . Seven and Eight Biopharmaceuticals Inc. is an experienced biopharmaceutical company committed to discovering and developing new and …See details»
Eight Biopharmaceuticals - Overview, News & Similar companies ...
Www.7and8biopharma.com. Revenue <$5 Million. Industry Manufacturing General Manufacturing . Recent News & Media. Seven and Eight Biopharmaceuticals Announces Exclusive Clini...See details»
Seven and Eight Biopharma - PitchBook
Seven and Eight Biopharma General Information Description. Operator of a biopharmaceutical company intended to treat cancer. The company's immunotherapies specialize in dendritic cell …See details»
Seven and Eight Biopharma Presents Promising Interim Phase 1 …
Nov 9, 2020 For more information, please visit www.7and8biopharma.com. Contacts. Seven and Eight Biopharmaceuticals Inc. Adam C. Zong, PhD, MBA President & COO (848) 300-0086 …See details»
Seven and Eight Biopharmaceuticals Announces Exclusive Clinical …
Jun 1, 2023 Robert Andtbacka, M.D, C.M. Chief Medical Officer Seven and Eight Biopharmaceuticals Inc. +1 (848) 300-0086 [email protected]. Release …See details»
Seven and Eight Biopharmaceuticals Inc. Announces the First …
Jun 23, 2021 Robert Andtbacka, MD, CM Chief Medical Officer Seven and Eight Biopharmaceuticals Inc. +1 (848) 300-0086 [email protected]. Contacts. Robert …See details»
Seven and Eight Biopharmaceuticals Inc. - CMOCRO
Seven and Eight Biopharmaceuticals Inc. is a biopharmaceutical company devoted to the discovery and development of new targeted cancer immunotherapies. The company is the …See details»
Seven and Eight Biopharma’s BDB001 in Combination with an
Nov 13, 2021 Seven and Eight Biopharmaceuticals Inc., a clinical stage biotechnology company developing proprietary novel immuno-oncology therapies to activate the immune system …See details»
Editor Details - PharmiWeb.com
Jun 1, 2023 EDISON, N.J.--(BUSINESS WIRE)--Seven and Eight Biopharmaceuticals Inc., a clinical stage biotechnology company focused on developing proprietary novel immuno …See details»
Seven and Eight Biopharma’s BDB001 in Combination ... - Business …
Jun 7, 2021 For more information, please visit www.7and8biopharma.com. Contacts. Robert Andtbacka, MD, CM Chief Medical Officer Seven and Eight Biopharmaceuticals Inc. +1 (848) …See details»
Editor Details - PharmiWeb.com
Jun 7, 2021 EDISON, N.J.--(BUSINESS WIRE)--Seven and Eight Biopharmaceuticals Inc., a clinical stage biotechnology company developing proprietary novel immuno-oncology …See details»
Seven and Eight Biopharma Presents Promising Interim Phase 1
Nov 9, 2020 EDISON, N.J.--(BUSINESS WIRE)-- Seven and Eight Biopharmaceuticals Inc., a clinical stage biotechnology company focused on developing proprietary novel immuno …See details»
Seven and Eight Biopharma’s BDB001 in Combination with
Jun 7, 2021 The poster presentation will be available on the ASCO Meeting Library and on the Company’s website at www.7and8biopharma.com. Abstract Summary: Seven and Eight …See details»
Seven and Eight Biopharmaceuticals Inc. Announces Clinical ...
Jun 20, 2019 Seven and Eight Biopharmaceuticals Inc. Contact: Adam C. Zong, PhD, MBA President & COO (848) 300-0086 [email protected]. Release Summary. Roche …See details»
Seven and Eight Biopharma Presents Promising Interim Phase 1 …
Nov 10, 2020 The poster presentation will be available for virtual viewing at the SITC meeting website until December 31, 2020 and will also be made available on the Company’s website at …See details»
Seven and Eight Biopharmaceuticals Inc. Announces the First
Jun 23, 2021 EDISON, N.J.--(BUSINESS WIRE)-- Seven and Eight Biopharmaceuticals Inc., a clinical stage biotechnology company focused on developing proprietary novel immuno …See details»
Seven and Eight Biopharmaceuticals Inc. Announces the First …
EDISON, NJ, USA I June 23, 2021 I Seven and Eight Biopharmaceuticals Inc., a clinical stage biotechnology company focused on developing proprietary novel immuno-oncology therapies …See details»